Diageo plc (NYSE:DEO) is one of the stocks Jim Cramer shed light on. Inquiring about the stock, a caller noted that the company might have a “new CEO turnaround story.” Here’s what Mad Money’s host had to say in response: “Okay, let me give you my, I think that the dividend at 5.6 can keep it here. They have to come up with something very special because I see a lot of their lines of business not doing well. Okay, I’m going to throw in Constellation and Brown-Forman, downgraded again, too. I don’t own sto ...

Daktronics, Inc. (NASDAQ:DAKT) is one of the stocks Jim Cramer shed light on. Asking if the stock is a buy, sell, or hold, a caller highlighted that the company has a new CEO and is institutionally held by BlackRock and others. In response, Cramer said: “You know, it’s just okay. I’ve never been excited about that scoreboard business, advertising, it’s just not compelling enough to put your money into.” A stock market graph. Photo by energepic.com Daktronics, Inc. (NASDAQ:DAKT) manufactures electronic ...

Lithium Americas Corp. (NYSE:LAC) is one of the stocks Jim Cramer shed light on. When a caller asked about the stock during the lightning round, Cramer stated: “No, no, there’s nothing there for you. We’re just going to have to skip it. That’s a yesteryear stock. It’s just, it’s a no-go.” Photo by Adam Nowakowski on Unsplash Lithium Americas Corp. (NYSE:LAC) operates lithium deposits and processing facilities, with its main project at Thacker Pass. It is worth noting that the stock is up over 50% year ...

Rocket Lab Corporation (NASDAQ:RKLB) is one of the stocks Jim Cramer shed light on. A caller asked if Cramer would include the stock “in the end of the year of magical investing,” and he commented: “I think Rocket Lab’s better than that. I don’t think it’s a magical thinking… I think it’s a very good spec ahead of another big offering in the rocket world next year. I think you can own it as your spec play, as I say in How to Make Money in Any Market.” Pixabay/Public Domain Rocket Lab Corporation (NASD ...

Elanco Animal Health Incorporated (NYSE:ELAN) is one of the stocks Jim Cramer shed light on. Answering a caller’s query about the stock, Cramer said: “They are doing everything right. I am so impressed with the way they’ve turned that company around. I’m glad you brought it out. That was a real good idea.” A laptop and a computer monitor display a detailed stock market technical analysis chart. Photo by Jakub Zerdzicki on Pexels Elanco Animal Health Incorporated (NYSE:ELAN) sells products to protect a ...

Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer shed light on. During the lightning round, a caller sought Cramer’s opinion on the stock, and he said: “Okay, Pfizer, really good yield, not a lot of momentum. Didn’t like the update yesterday. I’m going to say just weak hold.” Photo by Spencer Davis on Unsplash Pfizer Inc. (NYSE:PFE) creates and sells medicines and vaccines for several health conditions, including heart disease, infections, COVID-19, and rare diseases. Cramer was asked about the ...

Dover Corporation (NYSE:DOV) is one of the stocks Jim Cramer shed light on. During the episode, a caller inquired if the stock is a buy, sell, or hold, and Cramer remarked: “Oh, you know, I like Dover. It’s a short cycle name. It’s recommended by a bunch of people. The stock is finally getting the due that it’s worth. I think that Tobin’s doing a good job and I know he can do a lot of things. Got a great balance sheet. Stock’s on a real roll. I want to buy DOV, a club name.” Stock market data showing a ...

SoFi Technologies, Inc. (NASDAQ:SOFI) is one of the stocks Jim Cramer shed light on. Given the stock’s recent pullback, a caller asked if it is a good time to buy, sell, or hold it. In response, Cramer said: “Okay, SoFi stock is right now enjoying, I could say, a pullback, and I don’t want to buy it until I think we’re further along in the pullback because now it got a very high price-to-earnings multiple. Why don’t we wait to see if it can’t, you can’t get this stock at $20. You can buy a little, 23 say, ...

“So is Medline worth buying after today’s IPO and the stock’s subsequent rally? This was a very successful deal with the stock up more than 41% today. Initially, Medline was only looking to sell 179 million shares for $26 to $30, but the demand was so high that they sold over 216 million shares at $29. Today, Medline opened for trading at $35, up over 20% from the offer price, and then it added a few more bucks after that. At the current price, Medline has a market capitalization of roughly $54 billion, mak ...

Robinhood Markets, Inc. (NASDAQ:HOOD) is one of the stocks Jim Cramer shed light on. During the episode, a caller inquired if the stock is a buy, sell, or hold, and Cramer commented: “Okay, this stock just went up like just, I mean, straight up. And now, when they start coming down when they’ve been straight up, they don’t stop as fast as you’d like to see. That’s why what we’re going to do is let Robinhood come down below that last dip, which took it down to $103. Maybe you go to, say, $95 and then pull ...